2021 annual financial data
Sonoma Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -18.13%.
Operating income was -3,449,000 USD and net income was -3,950,000 USD.
Operating cash flow was -3,378,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,629,000 USD
- Operating income
- -3,449,000 USD
- Net income
- -3,950,000 USD
- Operating cash flow
- -3,378,000 USD